The Canadian Cancer Society (CCS) is proud to launch a new funding program in support of cancer research across Canada. The Challenge grant program will support cancer research projects across the cancer continuum and across disciplines, with an ultimate goal of solving a problem (i.e. a ‘challenge’) in cancer that will be meaningful to people affected by or at risk of cancer.
The Challenge grant program will support cancer research projects across the cancer continuum and across disciplines, with an ultimate goal of solving a problem (i.e. a ‘challenge’) in cancer that will be meaningful to people affected by or at risk of cancer. Whether culminating in outcomes that have immediate impact (such as a tool, therapeutic, program, policy, or practice change), or those that are more long term in scope (such as an important finding relevant to the biology or etiology of cancer that could eventually be applied to improve outcomes), applicants must clearly articulate the anticipated contribution of their proposed project towards solving the identified challenge, as well as an estimated timeline for success.
An applicant must hold a firm academic position (as a primary appointment) which allows the individual to engage in independent research activities for the duration of the project and includes the ability to supervise trainees and publish research results.
A researcher designated as the Principal Investigator must be based in, or formally affiliated with, an eligible Canadian Host Institution such as a university, research institute or health care agency. Graduate students, postdoctoral fellows, research associates, Adjunct Professors or Status only appointments (except where they hold a firm academic position at another Canadian institution), technical support staff, or investigators based outside of Canada are not eligible to be a Principal Investigator. Both the Principal Investigator and executive authorities of the Host Institution are required to agree to the terms of the Host Institution/Canadian Cancer Society Agreement included as part of the application, thereby acknowledging and agreeing to all the responsibilities and obligations outlined in that Agreement.
The person named as the PI remains the PI on a grant for the duration of the grant unless given express permission by the Canadian Cancer Society.
Abstract registrations due: July 28, 2021
Full applications due: September 22, 2021
Results announcement: January 2022
Anticipated start date: January 1, 2022